Introduction: A Nitrosamine Compliance Strategy for Biosimilars is fast becoming a required part of modern pharmaceutical quality and regulatory planning, … Continue reading Case Study: Nitrosamine Compliance Strategy for a Biosimilar Seeking Simultaneous FDA and EMA Approval